Header Logo
Keywords
Last Name
Institution
Announcement

You can now add alternative names! Click here to add other names that you've published under.
 Back to Profile

Janet Rader

Concepts (632)

Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Uterine Cervical Neoplasms
84
2022
275
13.280
 Why?
Ovarian Neoplasms
37
2024
448
2.870
 Why?
Papillomavirus Infections
18
2021
155
2.850
 Why?
Endometrial Neoplasms
34
2019
138
2.480
 Why?
Uterine Cervical Dysplasia
16
2017
49
2.470
 Why?
Carcinoma, Squamous Cell
31
2018
322
2.090
 Why?
Gene Expression Regulation, Neoplastic
18
2021
828
1.930
 Why?
Human papillomavirus 16
8
2019
44
1.770
 Why?
Female
190
2024
26668
1.620
 Why?
Gene Expression Profiling
9
2021
1041
1.580
 Why?
Papillomaviridae
16
2020
102
1.420
 Why?
Antineoplastic Combined Chemotherapy Protocols
17
2013
994
1.340
 Why?
DNA Methylation
21
2020
550
1.330
 Why?
Genital Neoplasms, Female
10
2018
41
1.230
 Why?
Human papillomavirus 18
5
2019
9
1.210
 Why?
Humans
191
2024
50251
1.180
 Why?
Genetic Predisposition to Disease
13
2024
507
1.150
 Why?
Adult
92
2024
13384
1.130
 Why?
Middle Aged
99
2024
12234
1.070
 Why?
Neoplasm Staging
41
2019
747
1.060
 Why?
Adenocarcinoma
18
2018
402
1.020
 Why?
Polymorphism, Single Nucleotide
10
2019
486
0.990
 Why?
Fluorodeoxyglucose F18
15
2022
194
0.970
 Why?
MicroRNAs
7
2019
355
0.970
 Why?
DNA-Binding Proteins
9
2021
428
0.960
 Why?
Neoplasm Recurrence, Local
19
2024
633
0.950
 Why?
Carcinoma
12
2010
139
0.920
 Why?
Oncogene Proteins, Viral
4
2019
52
0.870
 Why?
Radiopharmaceuticals
14
2022
208
0.820
 Why?
Cervix Uteri
7
2017
49
0.820
 Why?
Repressor Proteins
4
2019
153
0.810
 Why?
Alphapapillomavirus
1
2021
13
0.780
 Why?
DNA, Viral
6
2019
134
0.760
 Why?
Cell Line, Tumor
18
2021
1418
0.740
 Why?
Immunologic Factors
2
2014
114
0.730
 Why?
Neoplasm Invasiveness
15
2020
268
0.710
 Why?
Neoplasms
8
2022
1250
0.700
 Why?
Genetic Markers
8
2017
102
0.690
 Why?
Genes, Tumor Suppressor
8
2007
73
0.690
 Why?
Aged
70
2024
9427
0.680
 Why?
Neoplasm Proteins
10
2019
324
0.680
 Why?
Immunoglobulins
3
2017
80
0.670
 Why?
Genomics
4
2018
287
0.640
 Why?
Biomedical Research
1
2022
237
0.640
 Why?
Gene Silencing
5
2018
118
0.630
 Why?
Vascular Endothelial Growth Factor A
2
2017
202
0.560
 Why?
Cisplatin
7
2022
277
0.560
 Why?
Aged, 80 and over
36
2024
3140
0.550
 Why?
Proteomics
1
2019
327
0.540
 Why?
Promoter Regions, Genetic
12
2020
475
0.530
 Why?
HLA-C Antigens
2
2018
4
0.530
 Why?
Receptors, KIR
2
2018
13
0.530
 Why?
Positron-Emission Tomography
11
2013
293
0.510
 Why?
Ubiquitin Thiolesterase
2
2021
18
0.510
 Why?
Tumor Virus Infections
4
2006
42
0.510
 Why?
Microsatellite Repeats
14
2007
37
0.510
 Why?
Lymph Nodes
10
2010
263
0.500
 Why?
Hysterectomy
15
2022
88
0.490
 Why?
Disease-Free Survival
17
2013
454
0.490
 Why?
Gynecologic Surgical Procedures
4
2010
28
0.490
 Why?
Granulosa Cell Tumor
2
2024
2
0.470
 Why?
Phenotype
4
2016
732
0.470
 Why?
Prognosis
19
2021
1959
0.460
 Why?
Lymphatic Metastasis
14
2019
227
0.450
 Why?
Chromosomes, Human, Pair 6
4
2007
15
0.450
 Why?
Alleles
5
2017
250
0.450
 Why?
Immunohistochemistry
13
2024
978
0.440
 Why?
Nuclear Proteins
8
2009
243
0.440
 Why?
Loss of Heterozygosity
10
2007
77
0.440
 Why?
Ovary
2
2008
115
0.420
 Why?
Membrane Proteins
3
2005
353
0.410
 Why?
Genotype
9
2018
533
0.410
 Why?
Survival Analysis
14
2021
666
0.400
 Why?
Cell Movement
5
2021
249
0.400
 Why?
STAT3 Transcription Factor
3
2021
81
0.400
 Why?
Peritoneal Neoplasms
4
2008
61
0.390
 Why?
Ultrasonic Therapy
3
2001
34
0.390
 Why?
Carcinoma, Endometrioid
6
2014
38
0.390
 Why?
Genes, p53
2
2010
51
0.390
 Why?
Cell Proliferation
6
2021
1015
0.380
 Why?
Risk Factors
13
2019
3608
0.380
 Why?
Signal Transduction
8
2021
1624
0.370
 Why?
Uterine Neoplasms
5
2009
60
0.370
 Why?
Mutation
12
2018
1296
0.360
 Why?
Ascites
2
2008
29
0.360
 Why?
Carboplatin
2
2009
53
0.360
 Why?
Antibodies, Monoclonal
5
2021
461
0.360
 Why?
NAD(P)H Dehydrogenase (Quinone)
1
2010
13
0.350
 Why?
Antineoplastic Agents
9
2014
1186
0.350
 Why?
Proto-Oncogene Proteins c-mdm2
1
2010
12
0.350
 Why?
Cohort Studies
13
2024
1397
0.350
 Why?
Disease Progression
6
2020
827
0.350
 Why?
GTPase-Activating Proteins
1
2009
23
0.350
 Why?
Base Sequence
8
2019
644
0.340
 Why?
Membrane Glycoproteins
2
2009
247
0.340
 Why?
DNA, Neoplasm
11
2006
147
0.340
 Why?
Chromosomes, Human, Pair 11
3
2005
54
0.340
 Why?
Matrix Metalloproteinase 9
1
2009
89
0.330
 Why?
Neoplasms, Glandular and Epithelial
3
2006
41
0.330
 Why?
Brachytherapy
9
2014
48
0.330
 Why?
Proto-Oncogene Proteins c-myc
2
2021
50
0.330
 Why?
Combined Modality Therapy
11
2010
641
0.330
 Why?
Abdominal Neoplasms
1
2009
16
0.330
 Why?
DNA Repair
11
2007
193
0.320
 Why?
Retrospective Studies
33
2024
6172
0.320
 Why?
Laser Coagulation
1
2009
26
0.320
 Why?
Drug Administration Schedule
10
2013
374
0.310
 Why?
Deoxycytidine
4
2006
28
0.310
 Why?
Homeodomain Proteins
2
2006
80
0.310
 Why?
RNA-Binding Proteins
2
2021
123
0.310
 Why?
Microsatellite Instability
5
2019
18
0.310
 Why?
Germ-Line Mutation
3
2024
61
0.310
 Why?
Laparoscopy
3
2022
170
0.310
 Why?
Protozoan Proteins
1
2008
32
0.310
 Why?
Kaplan-Meier Estimate
6
2019
465
0.300
 Why?
Drug Resistance, Neoplasm
6
2016
316
0.290
 Why?
Ovariectomy
7
2010
115
0.290
 Why?
Antigens, CD
2
2007
221
0.290
 Why?
Chromosomes, Human, Pair 3
4
2001
19
0.280
 Why?
SOXC Transcription Factors
2
2019
13
0.280
 Why?
Heart Arrest
1
2009
151
0.280
 Why?
Polymerase Chain Reaction
9
2010
455
0.280
 Why?
Receptors, Estrogen
3
2024
131
0.280
 Why?
Topotecan
5
2013
17
0.270
 Why?
POU Domain Factors
1
2006
1
0.270
 Why?
Vulvar Neoplasms
5
2002
52
0.270
 Why?
Registries
6
2010
513
0.270
 Why?
Oligonucleotide Array Sequence Analysis
5
2010
412
0.270
 Why?
Neoplasm Metastasis
5
2021
236
0.260
 Why?
HeLa Cells
3
2021
261
0.260
 Why?
Anemia
3
2020
67
0.260
 Why?
Young Adult
7
2018
4002
0.260
 Why?
Survival Rate
10
2009
902
0.250
 Why?
Vaginal Smears
6
2006
27
0.250
 Why?
Breast Neoplasms
5
2018
1184
0.250
 Why?
Reverse Transcriptase Polymerase Chain Reaction
4
2007
594
0.240
 Why?
Chromosome Aberrations
1
2006
297
0.240
 Why?
Virus Integration
2
2021
8
0.230
 Why?
HSP70 Heat-Shock Proteins
1
2004
62
0.230
 Why?
Receptors, Androgen
1
2024
46
0.230
 Why?
Receptors, Progesterone
1
2024
64
0.230
 Why?
Cystadenocarcinoma, Papillary
2
2002
14
0.230
 Why?
Oxidoreductases Acting on CH-NH Group Donors
1
2003
16
0.230
 Why?
Oncostatin M
2
2021
5
0.220
 Why?
Quinazolines
1
2003
33
0.220
 Why?
Genome-Wide Association Study
2
2017
166
0.220
 Why?
Antigens, Neoplasm
1
2004
152
0.220
 Why?
Polymorphism, Genetic
5
2018
181
0.220
 Why?
Small Cell Lung Carcinoma
1
2023
26
0.210
 Why?
Omentum
1
2002
15
0.210
 Why?
Case-Control Studies
7
2019
1132
0.210
 Why?
Treatment Outcome
23
2014
5186
0.210
 Why?
Chromosome Deletion
3
2000
140
0.210
 Why?
Linkage Disequilibrium
3
2017
37
0.200
 Why?
Proto-Oncogene Proteins c-akt
2
2014
157
0.200
 Why?
Neoadjuvant Therapy
2
2022
118
0.200
 Why?
Antibodies, Monoclonal, Humanized
5
2013
225
0.200
 Why?
Genetic Variation
4
2019
215
0.200
 Why?
Tumor Microenvironment
2
2021
233
0.200
 Why?
Postoperative Complications
3
2022
1001
0.200
 Why?
Eukaryotic Initiation Factor-4F
1
2021
1
0.200
 Why?
Base Pair Mismatch
5
2006
22
0.200
 Why?
CA-125 Antigen
3
2008
17
0.200
 Why?
Chemoradiotherapy
1
2022
41
0.200
 Why?
Suction
1
2001
24
0.200
 Why?
Oncostatin M Receptor beta Subunit
1
2021
1
0.200
 Why?
Smoking
1
2005
507
0.190
 Why?
Colorectal Neoplasms
3
2002
238
0.190
 Why?
Radiotherapy, Conformal
2
2014
53
0.190
 Why?
Proteins
5
2008
345
0.190
 Why?
Carcinoma in Situ
2
2013
72
0.190
 Why?
Adaptor Proteins, Signal Transducing
8
2007
198
0.190
 Why?
Antimetabolites, Antineoplastic
2
2002
38
0.190
 Why?
Gene Regulatory Networks
2
2019
107
0.180
 Why?
Fetofetal Transfusion
1
2020
6
0.180
 Why?
Polycythemia
1
2020
9
0.180
 Why?
Pregnancy, Twin
1
2020
8
0.180
 Why?
Minority Groups
1
2022
132
0.180
 Why?
Radiotherapy
3
2010
126
0.180
 Why?
Twins, Monozygotic
1
2020
17
0.180
 Why?
Sarcoma
3
2009
67
0.180
 Why?
Lymph Node Excision
7
2019
138
0.180
 Why?
Genetic Diseases, Inborn
1
2000
23
0.180
 Why?
Transcriptome
2
2020
320
0.180
 Why?
Patient Satisfaction
2
2006
277
0.180
 Why?
Phosphoproteins
2
2016
108
0.180
 Why?
Receptor, erbB-3
1
2020
1
0.180
 Why?
Furin
1
2020
3
0.180
 Why?
HLA-DQ Antigens
1
2000
3
0.180
 Why?
Receptor, IGF Type 1
1
2020
20
0.180
 Why?
Tomography, X-Ray Computed
7
2013
1169
0.170
 Why?
Mice, Nude
4
2021
254
0.170
 Why?
Tumor Cells, Cultured
7
2021
468
0.170
 Why?
RNA, Neoplasm
3
2007
45
0.170
 Why?
Prenatal Diagnosis
1
2020
106
0.170
 Why?
Students
1
2022
211
0.170
 Why?
Antibodies, Neoplasm
1
2019
28
0.170
 Why?
Papillomavirus E7 Proteins
2
2017
31
0.170
 Why?
Adolescent
13
2018
6402
0.170
 Why?
NM23 Nucleoside Diphosphate Kinases
1
2019
4
0.170
 Why?
Placenta
1
2020
132
0.160
 Why?
Reproducibility of Results
2
2022
1189
0.160
 Why?
Follow-Up Studies
13
2019
2180
0.160
 Why?
Indocyanine Green
1
2019
34
0.160
 Why?
Doxorubicin
4
2009
238
0.160
 Why?
Decision Making
1
2001
268
0.160
 Why?
Fallopian Tube Neoplasms
3
2008
14
0.160
 Why?
Salvage Therapy
3
2008
139
0.160
 Why?
Cyclooxygenase 2
2
2017
45
0.150
 Why?
Sequence Analysis, DNA
1
2019
238
0.150
 Why?
Lung Neoplasms
2
2023
609
0.150
 Why?
Transcription Factors
1
2021
564
0.150
 Why?
HLA-DRB1 Chains
1
2017
4
0.150
 Why?
HLA-B Antigens
1
2017
6
0.150
 Why?
Metabolic Networks and Pathways
1
2018
89
0.150
 Why?
DNA Copy Number Variations
1
2018
110
0.150
 Why?
Receptors, Vitronectin
1
1997
1
0.150
 Why?
Tumor Suppressor Proteins
3
2005
128
0.150
 Why?
Proto-Oncogene Proteins
5
2004
149
0.140
 Why?
Carcinoma, Adenosquamous
3
2009
8
0.140
 Why?
DNA Mutational Analysis
9
2005
176
0.140
 Why?
Interleukin-10
1
2017
84
0.140
 Why?
Adipose Tissue
1
2019
187
0.140
 Why?
Bayes Theorem
1
2017
108
0.140
 Why?
Cyclooxygenase 2 Inhibitors
1
2017
19
0.140
 Why?
In Situ Hybridization
3
2008
64
0.140
 Why?
Leukocytes, Mononuclear
1
2017
115
0.140
 Why?
Protein Binding
1
2019
668
0.140
 Why?
Radiotherapy, Intensity-Modulated
2
2009
174
0.140
 Why?
Gene Expression Regulation, Viral
1
2017
48
0.140
 Why?
Risk Assessment
9
2019
1257
0.140
 Why?
Animals
10
2021
13285
0.140
 Why?
Body Mass Index
3
2010
654
0.140
 Why?
Radiotherapy Dosage
8
2014
246
0.140
 Why?
Radiation Injuries
3
2008
113
0.130
 Why?
ROC Curve
1
2017
233
0.130
 Why?
Taxoids
3
2006
37
0.130
 Why?
Carrier Proteins
7
2006
307
0.130
 Why?
Diagnosis, Differential
4
2024
1043
0.130
 Why?
Biopsy
5
2006
591
0.130
 Why?
Prospective Studies
10
2019
2379
0.130
 Why?
Estrogens
1
2017
223
0.130
 Why?
Colposcopy
3
2006
18
0.130
 Why?
Molecular Sequence Data
5
2009
793
0.130
 Why?
Wound Healing
2
2018
205
0.130
 Why?
Cells, Cultured
2
2017
1583
0.130
 Why?
Carcinosarcoma
3
2019
18
0.120
 Why?
Double-Blind Method
1
2017
683
0.120
 Why?
Algorithms
1
2019
618
0.120
 Why?
Mice
6
2021
5770
0.120
 Why?
Ultrasonography, Doppler, Color
1
1995
32
0.120
 Why?
Sensitivity and Specificity
4
2006
869
0.120
 Why?
Protein Kinase Inhibitors
2
2014
207
0.120
 Why?
Apoptosis
2
2021
1115
0.120
 Why?
Aneurysm
1
1995
33
0.120
 Why?
Dose-Response Relationship, Drug
6
2008
1377
0.120
 Why?
DNA Primers
2
2006
207
0.120
 Why?
Phosphatidylinositol 3-Kinases
2
2014
140
0.120
 Why?
Platinum Compounds
4
2008
10
0.120
 Why?
Obesity
5
2010
1106
0.120
 Why?
Heterocyclic Compounds, 3-Ring
1
2014
4
0.120
 Why?
Cyclohexanones
1
2014
7
0.120
 Why?
Colorectal Neoplasms, Hereditary Nonpolyposis
2
2004
11
0.120
 Why?
Embolization, Therapeutic
1
1995
86
0.110
 Why?
Transcriptional Activation
2
2019
121
0.110
 Why?
Camptothecin
3
2010
16
0.110
 Why?
TOR Serine-Threonine Kinases
1
2014
77
0.110
 Why?
Genetic Association Studies
1
2014
116
0.110
 Why?
Introns
1
2013
48
0.110
 Why?
Hypercalcemia
1
1993
33
0.110
 Why?
Paclitaxel
4
2007
85
0.110
 Why?
Decision Support Techniques
2
2010
71
0.110
 Why?
Chromosome Mapping
3
2005
156
0.110
 Why?
Pyridines
1
2014
132
0.110
 Why?
Cell Transformation, Neoplastic
2
2006
179
0.110
 Why?
Brain Neoplasms
1
2016
289
0.100
 Why?
Dermatologic Surgical Procedures
1
1992
34
0.100
 Why?
Models, Genetic
1
2012
170
0.100
 Why?
Tomography, Emission-Computed
4
2005
53
0.100
 Why?
Keratinocytes
2
2006
90
0.100
 Why?
Groin
2
2002
16
0.100
 Why?
RNA, Messenger
4
2021
1108
0.100
 Why?
Glucose
1
2014
339
0.100
 Why?
Cystadenocarcinoma, Serous
2
2024
71
0.100
 Why?
Laser Therapy
1
1992
84
0.100
 Why?
Exons
3
2007
95
0.100
 Why?
Pyrazoles
2
2023
115
0.100
 Why?
Infusions, Intravenous
4
2006
214
0.100
 Why?
Heterozygote
2
2004
81
0.100
 Why?
Condylomata Acuminata
1
1991
4
0.100
 Why?
Magnetic Resonance Imaging
3
2014
1542
0.100
 Why?
Models, Statistical
1
2012
224
0.100
 Why?
Epithelium
2
2007
65
0.090
 Why?
Goserelin
1
2010
1
0.090
 Why?
Decision Trees
1
2010
19
0.090
 Why?
Estrogen Antagonists
1
2010
21
0.090
 Why?
Ileal Diseases
1
1990
4
0.090
 Why?
Predictive Value of Tests
6
2010
914
0.090
 Why?
Leiomyoma
1
1990
25
0.090
 Why?
Epigenesis, Genetic
2
2019
378
0.090
 Why?
Cell Differentiation
2
2009
652
0.090
 Why?
Polymorphism, Restriction Fragment Length
1
2010
66
0.090
 Why?
Restriction Mapping
3
2006
32
0.090
 Why?
Gastrointestinal Hemorrhage
1
1990
79
0.090
 Why?
Colonic Neoplasms
2
2004
159
0.090
 Why?
Skin Transplantation
1
1990
44
0.090
 Why?
Age Factors
4
2006
1088
0.080
 Why?
Down-Regulation
4
2020
349
0.080
 Why?
Fluorouracil
2
2006
54
0.080
 Why?
Maximum Tolerated Dose
5
2010
38
0.080
 Why?
Endometrium
3
2019
41
0.080
 Why?
Genome, Human
2
2008
111
0.080
 Why?
Urinary Bladder Diseases
1
2009
18
0.080
 Why?
Intestinal Diseases
1
2009
25
0.080
 Why?
Lasers, Gas
1
2009
7
0.080
 Why?
Embolism, Air
1
2009
12
0.080
 Why?
Transcription, Genetic
4
2019
370
0.080
 Why?
Lymphatic Vessels
1
2009
53
0.080
 Why?
Vaginal Neoplasms
2
2005
4
0.080
 Why?
Adenocarcinoma, Clear Cell
3
2019
34
0.080
 Why?
Fluorine Radioisotopes
1
2008
24
0.080
 Why?
Primary Ovarian Insufficiency
1
2008
4
0.080
 Why?
Infertility, Female
1
2008
18
0.080
 Why?
Eimeria
1
2008
3
0.080
 Why?
Haplotypes
2
2017
84
0.080
 Why?
Polyethylene Glycols
2
2006
92
0.080
 Why?
Ubiquitin
1
2008
45
0.080
 Why?
Up-Regulation
2
2020
452
0.080
 Why?
Cell Cycle Proteins
1
2009
166
0.080
 Why?
Tumor Burden
2
2021
131
0.080
 Why?
Cricetinae
1
2008
212
0.080
 Why?
Expressed Sequence Tags
1
2007
8
0.080
 Why?
Angiogenesis Inhibitors
2
2006
188
0.080
 Why?
Infusion Pumps
1
1987
13
0.070
 Why?
Fluorescent Antibody Technique
1
2007
114
0.070
 Why?
Diagnostic Imaging
1
2009
178
0.070
 Why?
Microdissection
1
2007
19
0.070
 Why?
Precancerous Conditions
2
2005
83
0.070
 Why?
Models, Biological
2
2008
726
0.070
 Why?
MutS Homolog 2 Protein
5
2007
12
0.070
 Why?
Aorta
3
2005
162
0.070
 Why?
Stromal Cells
1
2007
72
0.070
 Why?
Organ Specificity
2
2018
107
0.070
 Why?
Codon
2
2003
47
0.070
 Why?
Lasers
1
2007
123
0.070
 Why?
Pelvic Floor
1
2007
51
0.070
 Why?
RNA, Double-Stranded
1
2006
21
0.070
 Why?
Neutropenia
1
2007
115
0.070
 Why?
Polymorphism, Single-Stranded Conformational
6
2003
19
0.070
 Why?
Recombinant Proteins
1
2008
489
0.070
 Why?
Tissue Fixation
1
2006
37
0.070
 Why?
Intestinal Perforation
2
2006
23
0.070
 Why?
Specimen Handling
1
2006
55
0.070
 Why?
Pulmonary Embolism
1
1987
97
0.070
 Why?
Protein Kinases
1
2006
72
0.070
 Why?
Head and Neck Neoplasms
2
2016
294
0.070
 Why?
Chromosomes, Artificial, Yeast
3
2000
6
0.070
 Why?
Endometrial Hyperplasia
2
2002
14
0.060
 Why?
Proportional Hazards Models
4
2010
407
0.060
 Why?
Abdomen
1
2006
78
0.060
 Why?
Papillomavirus Vaccines
1
2006
61
0.060
 Why?
Recurrence
4
2010
661
0.060
 Why?
Probability
4
2007
163
0.060
 Why?
Dibenzocycloheptenes
1
2004
1
0.060
 Why?
Terminal Care
1
2005
46
0.060
 Why?
Neovascularization, Pathologic
1
2006
162
0.060
 Why?
Tumor Suppressor Protein p53
1
2006
203
0.060
 Why?
Male
11
2018
25483
0.060
 Why?
Radiation-Sensitizing Agents
1
2005
53
0.060
 Why?
Quinolines
1
2004
41
0.060
 Why?
Cell Adhesion Molecules
1
2005
89
0.060
 Why?
Amyloid
1
2004
26
0.060
 Why?
Tissue Distribution
1
2004
163
0.060
 Why?
Genes, Viral
1
2003
37
0.060
 Why?
Lactones
1
2003
26
0.060
 Why?
Abdomen, Acute
1
2003
6
0.060
 Why?
Enzyme-Linked Immunosorbent Assay
1
2004
244
0.060
 Why?
Thrombospondins
1
2003
8
0.060
 Why?
Biopsy, Needle
4
2006
181
0.060
 Why?
Methylenetetrahydrofolate Reductase (NADPH2)
1
2003
57
0.060
 Why?
Obesity, Morbid
1
2004
77
0.060
 Why?
Pyrimidinones
1
2023
18
0.060
 Why?
RNA, Viral
2
2016
125
0.050
 Why?
Fibroma
1
2003
39
0.050
 Why?
Clinical Competence
1
2006
397
0.050
 Why?
Neoplasms, Second Primary
1
2004
78
0.050
 Why?
Congenital Abnormalities
1
2004
112
0.050
 Why?
Radiotherapy, Adjuvant
3
2010
62
0.050
 Why?
Uterine Hemorrhage
1
2002
11
0.050
 Why?
Age of Onset
2
2004
106
0.050
 Why?
Pneumatosis Cystoides Intestinalis
1
2002
7
0.050
 Why?
PTEN Phosphohydrolase
2
2019
55
0.050
 Why?
DNA, Ribosomal
1
2002
28
0.050
 Why?
Blood Transfusion, Autologous
1
2002
4
0.050
 Why?
Chromatography, High Pressure Liquid
1
2003
327
0.050
 Why?
Genital Diseases, Female
1
2002
17
0.050
 Why?
Acridines
1
2002
4
0.050
 Why?
Postmenopause
1
2002
76
0.050
 Why?
Medical History Taking
1
2002
47
0.050
 Why?
Pregnancy
3
2020
2605
0.050
 Why?
Medical Records
1
2002
86
0.050
 Why?
Blood Donors
1
2002
31
0.050
 Why?
Complementary Therapies
1
2002
25
0.050
 Why?
AU Rich Elements
1
2021
1
0.050
 Why?
Family Health
1
2002
81
0.050
 Why?
Peptide Chain Initiation, Translational
1
2021
15
0.050
 Why?
RNA Stability
1
2021
24
0.050
 Why?
Cytokine Receptor gp130
1
2021
12
0.050
 Why?
3' Untranslated Regions
1
2021
52
0.050
 Why?
Receptors, Transforming Growth Factor beta
1
2001
25
0.050
 Why?
Lymphatic Irradiation
1
2001
1
0.050
 Why?
Blotting, Northern
2
2001
109
0.050
 Why?
Prostaglandin-Endoperoxide Synthases
1
2001
26
0.050
 Why?
Blotting, Southern
3
2002
42
0.050
 Why?
Xenograft Model Antitumor Assays
1
2021
213
0.050
 Why?
Phosphoric Monoester Hydrolases
1
2000
21
0.050
 Why?
Internship and Residency
1
2006
441
0.050
 Why?
Equipment Design
1
2001
283
0.050
 Why?
Catheterization, Central Venous
1
2001
84
0.050
 Why?
Blood Vessels
1
2001
71
0.050
 Why?
Uganda
1
2020
36
0.050
 Why?
Incidence
3
2007
986
0.050
 Why?
Logistic Models
2
2017
891
0.040
 Why?
Quality Improvement
1
2022
209
0.040
 Why?
Isoenzymes
1
2001
169
0.040
 Why?
Risk Management
1
2000
32
0.040
 Why?
Physical Chromosome Mapping
1
2000
8
0.040
 Why?
beta Karyopherins
1
2019
4
0.040
 Why?
Patient Discharge
1
2022
318
0.040
 Why?
Interviews as Topic
1
2001
259
0.040
 Why?
Acid Anhydride Hydrolases
1
1999
15
0.040
 Why?
Cell Survival
1
2021
602
0.040
 Why?
DNA Repair Enzymes
1
1999
44
0.040
 Why?
Adenosine Triphosphatases
1
1999
87
0.040
 Why?
Cell Nucleus
1
2019
188
0.040
 Why?
Cross-Sectional Studies
1
2024
1557
0.040
 Why?
Molecular Targeted Therapy
1
2019
121
0.040
 Why?
Regression Analysis
3
2006
393
0.040
 Why?
Pregnancy Outcome
1
2020
237
0.040
 Why?
Chromosomes, Human, Pair 10
1
1998
3
0.040
 Why?
Coloring Agents
1
2019
70
0.040
 Why?
Gene Dosage
1
2018
78
0.040
 Why?
Histone Demethylases
1
2018
16
0.040
 Why?
Th1-Th2 Balance
1
2018
2
0.040
 Why?
Epithelial-Mesenchymal Transition
1
2018
48
0.040
 Why?
Leptin
1
2019
140
0.040
 Why?
Estradiol
1
2019
215
0.040
 Why?
Major Histocompatibility Complex
1
2017
12
0.040
 Why?
Databases, Genetic
1
2018
88
0.040
 Why?
Genotyping Techniques
1
2017
20
0.040
 Why?
Child
4
2018
6854
0.040
 Why?
Chemokines
1
2017
78
0.040
 Why?
Receptors, Collagen
1
1997
3
0.040
 Why?
Receptors, Fibronectin
1
1997
5
0.040
 Why?
Mass Screening
1
2000
346
0.040
 Why?
Time Factors
4
2010
2911
0.040
 Why?
Interferon-gamma
1
2018
176
0.040
 Why?
Coculture Techniques
1
2017
146
0.040
 Why?
Transforming Growth Factor beta
1
2018
144
0.040
 Why?
Integrins
1
1997
31
0.040
 Why?
Chemotherapy, Adjuvant
2
2010
122
0.040
 Why?
Quality-Adjusted Life Years
2
2010
63
0.040
 Why?
Diet, High-Fat
1
2019
220
0.030
 Why?
Longitudinal Studies
1
2019
687
0.030
 Why?
Hepatitis Viruses
1
2016
2
0.030
 Why?
Epithelial Cells
2
2006
208
0.030
 Why?
Herpesviridae
1
2016
17
0.030
 Why?
Viruses
1
2016
22
0.030
 Why?
Host-Pathogen Interactions
1
2017
135
0.030
 Why?
Gastrointestinal Neoplasms
1
2016
44
0.030
 Why?
Mice, Transgenic
1
2017
551
0.030
 Why?
DNA Replication
1
1997
152
0.030
 Why?
Cost-Benefit Analysis
2
2010
271
0.030
 Why?
Plasmids
2
2001
163
0.030
 Why?
Sequence Analysis, RNA
1
2016
91
0.030
 Why?
Central Nervous System Neoplasms
1
2016
64
0.030
 Why?
Electrosurgery
1
1995
7
0.030
 Why?
Fibroblasts
1
2017
351
0.030
 Why?
Macrophages
1
2018
364
0.030
 Why?
Prostatic Neoplasms
1
1998
394
0.030
 Why?
CpG Islands
2
2008
107
0.030
 Why?
DNA Probes, HPV
2
1991
3
0.030
 Why?
Arteries
1
1995
92
0.030
 Why?
Computational Biology
1
2016
216
0.030
 Why?
Cytokines
1
2017
615
0.030
 Why?
Class I Phosphatidylinositol 3-Kinases
1
2014
18
0.030
 Why?
Multivariate Analysis
2
2009
578
0.030
 Why?
Treatment Failure
2
2008
116
0.030
 Why?
Missouri
2
2006
61
0.030
 Why?
Organs at Risk
1
2014
70
0.030
 Why?
Inclusion Bodies
1
1993
17
0.030
 Why?
Parathyroid Hormone-Related Protein
1
1993
23
0.030
 Why?
Cell Division
2
1994
295
0.030
 Why?
Cell Death
1
2014
181
0.030
 Why?
Imaging, Three-Dimensional
1
2014
153
0.030
 Why?
Risk
2
2004
315
0.030
 Why?
Skin Physiological Phenomena
1
1992
15
0.030
 Why?
Guinea Pigs
1
1992
75
0.030
 Why?
Epidermis
1
1992
28
0.030
 Why?
Pelvis
2
2004
67
0.030
 Why?
Pedigree
2
2004
125
0.030
 Why?
Deoxyglucose
1
2012
36
0.020
 Why?
Colectomy
1
1992
28
0.020
 Why?
Regeneration
1
1992
72
0.020
 Why?
Computer Simulation
1
2012
282
0.020
 Why?
Pilot Projects
2
2004
704
0.020
 Why?
Sequence Deletion
2
2003
68
0.020
 Why?
Premenopause
1
2010
24
0.020
 Why?
Amino Acid Sequence
2
2003
587
0.020
 Why?
Staurosporine
1
2010
12
0.020
 Why?
Anastomosis, Surgical
1
1990
66
0.020
 Why?
Remission Induction
1
2010
207
0.020
 Why?
Molecular Weight
1
1990
85
0.020
 Why?
Proto-Oncogene Proteins p21(ras)
2
2001
66
0.020
 Why?
ras Proteins
2
2001
64
0.020
 Why?
Cicatrix
1
1990
40
0.020
 Why?
Hemoglobins
1
1990
107
0.020
 Why?
Staining and Labeling
1
1990
97
0.020
 Why?
Chi-Square Distribution
1
2010
278
0.020
 Why?
Perioperative Care
1
2009
42
0.020
 Why?
Urinary Incontinence
1
2009
38
0.020
 Why?
Organoplatinum Compounds
1
2008
14
0.020
 Why?
Gene Knockdown Techniques
1
2009
106
0.020
 Why?
Vinblastine
1
2008
23
0.020
 Why?
Fetus
1
1990
216
0.020
 Why?
Life Style
1
2009
140
0.020
 Why?
Dose-Response Relationship, Radiation
1
2008
184
0.020
 Why?
Emotions
1
2009
165
0.020
 Why?
Demography
1
2007
93
0.020
 Why?
Cadherins
1
2007
68
0.020
 Why?
Cell Line
1
1990
1024
0.020
 Why?
Intracellular Signaling Peptides and Proteins
1
2008
143
0.020
 Why?
Cytoplasmic Structures
1
2006
1
0.020
 Why?
DNA Mismatch Repair
1
2006
16
0.020
 Why?
Skin
1
1990
415
0.020
 Why?
Waxes
1
2006
1
0.020
 Why?
Tissue Embedding
1
2006
1
0.020
 Why?
Eukaryotic Initiation Factor-2
1
2006
18
0.020
 Why?
NIH 3T3 Cells
1
2006
52
0.020
 Why?
Immunoenzyme Techniques
2
2001
145
0.020
 Why?
Tomography Scanners, X-Ray Computed
1
2006
12
0.020
 Why?
Chromosomal Instability
1
2006
16
0.020
 Why?
Neoplasm, Residual
1
2007
165
0.020
 Why?
Cryopreservation
1
2006
31
0.020
 Why?
Genome, Viral
1
2006
79
0.020
 Why?
Analysis of Variance
1
2007
563
0.020
 Why?
Transfection
1
2006
355
0.020
 Why?
Mutation, Missense
1
2006
106
0.020
 Why?
Nurse Practitioners
1
2006
42
0.020
 Why?
Gynecology
1
2006
49
0.020
 Why?
Gene Expression
1
2008
615
0.020
 Why?
Ovarian Cysts
1
2005
4
0.020
 Why?
Sarcoma, Endometrial Stromal
1
2005
1
0.020
 Why?
Medical Futility
1
2005
8
0.020
 Why?
Early Diagnosis
1
2006
87
0.020
 Why?
Cyclophosphamide
1
2006
166
0.020
 Why?
Triage
1
2006
63
0.020
 Why?
Leiomyosarcoma
1
2005
23
0.020
 Why?
Hospice Care
1
2005
26
0.020
 Why?
Cytodiagnosis
1
2005
42
0.020
 Why?
Health Services
1
2005
67
0.020
 Why?
Phosphorylation
1
2006
534
0.020
 Why?
Obstetrics
1
2006
88
0.020
 Why?
Lymphatic System
1
2004
14
0.010
 Why?
Penetrance
1
2004
6
0.010
 Why?
Area Under Curve
1
2004
178
0.010
 Why?
Microscopy, Electron, Transmission
1
2004
75
0.010
 Why?
Calcification, Physiologic
1
2004
41
0.010
 Why?
Laparotomy
1
2004
35
0.010
 Why?
Bryostatins
1
2003
1
0.010
 Why?
Macrolides
1
2003
16
0.010
 Why?
Ethanol
1
2006
341
0.010
 Why?
Genomic Instability
1
2004
93
0.010
 Why?
Thrombospondin 1
1
2003
7
0.010
 Why?
Tamoxifen
1
2004
60
0.010
 Why?
Genes, p16
1
2003
9
0.010
 Why?
Codon, Terminator
1
2003
8
0.010
 Why?
Confidence Intervals
1
2003
156
0.010
 Why?
Administration, Oral
1
2004
435
0.010
 Why?
Frameshift Mutation
1
2003
17
0.010
 Why?
Mutagenesis, Insertional
1
2003
24
0.010
 Why?
Liposomes
1
2003
53
0.010
 Why?
Palliative Care
1
2005
186
0.010
 Why?
Body Weight
1
2005
514
0.010
 Why?
Cytoskeletal Proteins
1
2003
49
0.010
 Why?
DNA Transposable Elements
1
2003
107
0.010
 Why?
Physicians
1
2006
227
0.010
 Why?
Prevalence
1
2006
953
0.010
 Why?
Reference Values
1
2003
309
0.010
 Why?
Retinoblastoma-Like Protein p130
1
2002
8
0.010
 Why?
beta Catenin
1
2003
102
0.010
 Why?
Retinoblastoma Protein
1
2002
19
0.010
 Why?
Ifosfamide
1
2002
9
0.010
 Why?
Documentation
1
2002
34
0.010
 Why?
Trans-Activators
1
2003
134
0.010
 Why?
Bleomycin
1
2002
35
0.010
 Why?
Hospitals, University
1
2002
77
0.010
 Why?
Antineoplastic Agents, Alkylating
1
2002
74
0.010
 Why?
Age Distribution
1
2002
167
0.010
 Why?
Equipment Failure
1
2001
63
0.010
 Why?
Statistics, Nonparametric
1
2002
193
0.010
 Why?
Nucleic Acid Hybridization
2
1991
54
0.010
 Why?
Antibiotics, Antineoplastic
1
2002
80
0.010
 Why?
Carcinoma, Small Cell
1
2001
25
0.010
 Why?
Genes, erbB-1
1
2001
8
0.010
 Why?
Outpatients
1
2002
112
0.010
 Why?
Radiography
1
2002
490
0.010
 Why?
Hospitalization
1
2005
663
0.010
 Why?
Repetitive Sequences, Nucleic Acid
1
2000
96
0.010
 Why?
DNA
1
2004
542
0.010
 Why?
Mitogen-Activated Protein Kinases
1
2001
155
0.010
 Why?
Genetic Linkage
1
2000
26
0.010
 Why?
Chromosomes, Human, Pair 2
1
2000
25
0.010
 Why?
Morbidity
1
2000
134
0.010
 Why?
Blotting, Western
1
2001
601
0.010
 Why?
Gene Deletion
1
2000
270
0.010
 Why?
Carcinoma, Non-Small-Cell Lung
1
2001
156
0.010
 Why?
Chromosomes, Bacterial
1
1998
14
0.010
 Why?
Cloning, Molecular
1
1998
185
0.010
 Why?
Infant
1
2006
3560
0.010
 Why?
Child, Preschool
1
2006
3877
0.010
 Why?
Drug Resistance, Multiple
1
1997
24
0.010
 Why?
Antineoplastic Agents, Phytogenic
1
1997
71
0.010
 Why?
Gene Frequency
1
1997
95
0.010
 Why?
United States
1
2007
4887
0.010
 Why?
Ambulatory Surgical Procedures
1
1995
46
0.010
 Why?
Dimethyl Sulfoxide
1
1994
12
0.010
 Why?
Glycerol
1
1994
15
0.010
 Why?
Drug Screening Assays, Antitumor
1
1994
140
0.010
 Why?
Drug Carriers
1
1994
71
0.010
 Why?
Cell Cycle
1
1994
232
0.010
 Why?
Retroperitoneal Space
1
1991
32
0.010
 Why?
Rader's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (632) concept(s)
_
Co-Authors Expand Description
See all (1) people
_
Similar People Expand Description
See all (36) people
_
Same Department Expand Description
Search Department